selected scholarly activity
-
chapters
- Venous Thromboembolism. 2102-2112. 2018
- Venous Thromboembolism. 2102-2112. 2017
-
conferences
- Values and Preferences Towards Antithrombotic Therapy in Patients with Myeloproliferative Neoplasms: A Qualitative Study. Blood. 13280-13281. 2022
- A Population Cohort Study to Evaluate the Risk of Ischemic Stroke Among Individuals with a New Diagnosis of Cancer Compared to Matched Cancer-Free Controls: Impact of Prior Stroke History. Blood. 175-175. 2021
- Risks and Benefits of Antithrombotic Therapy in Polycythemia Vera: A Systematic Review. Thrombosis Research. 6-6. 2019
- Blood Loss From Laboratory Testing in the Intensive Care Unit and Transfusion: A Retrospective Study. Transfusion. 208A-208A. 2019
- MANAGEMENT OF ANTITHROMBOTIC THERAPY AFTER GASTROINTESTINAL BLEEDING: A QUALITATIVE STUDY OF HEALTHCARE PROVIDERS. Gastroenterology. S750-S751. 2019
- Reducing Unnecessary Blood Tests in the Critically Ill (RUBIC): A Multi-Center Prospective Audit. American Journal of Respiratory and Critical Care Medicine. 2019
- Blood Loss Due to Laboratory Testing in Critical Care Patients: A Retrospective Cohort Study. Blood. 4885-4885. 2018
- Small-Volume Tubes to Reduce Transufusion (STRATUS): A Pilot Study. Blood. 825-825. 2018
- 2. Abstract Title: Risk of venous and arterial thrombosis in patients receiving tranexamic acid: A systematic review and meta-analysis. Thrombosis Research. 2-2. 2018
- Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score?. European Heart Journal. 1007-1008. 2018
- Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2VASc score of 2 or higher?. European Heart Journal. 821-821. 2018
- RESUMPTION OF ANTICOAGULANT THERAPY AFTER ANTICOAGULANT-RELATED GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. S220-S220. 2018
- Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score?. Acta Cardiologica. 484-485. 2018
- Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2-Vasc score >= 2?. Acta Cardiologica. 481-482. 2018
- The Real-World Treatment of Polycythemia Vera: Adherence to Treatment Guidelines and Outcomes. Blood. 2017
- Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery. Blood. 1130-1130. 2015
- Non-Specific Hemostatic Agents (PCC, aPCC, rVIIa) for Reversal of Direct Oral Anticoagulant Effect in Patients with Major Bleeding Complications: A Retrospective Review. Blood. 1137-1137. 2015
- Initiating thromboprophylaxis with rivaroxaban up to 26 h after elective knee arthroplasty does not increase the incidence of venous thromboembolism. Journal of Thrombosis and Haemostasis. 391-391. 2015
- Interventions to reduce blood loss from laboratory testing in critically ill patients and impact on transfusion: a systematic review. Journal of Thrombosis and Haemostasis. 974-975. 2015
- Efficacy and safety of weight-adjusted extended duration tinzaparin for prevention of post-operative venous thromboembolism after bariatric surgery. Journal of Thrombosis and Haemostasis. 821-821. 2013
- Reversal of oral direct thrombin and factor Xa inhibitors: a systematic review. Journal of Thrombosis and Thrombolysis. 413-413. 2013
- Perioperative Heparin Bridging in Patients Receiving Oral Anticoagulation: Meta-Analysis of Bleeding and Thromboembolic Rates. Blood. 545-545. 2011
- Perioperative heparin bridging in patients receiving oral anticoagulation: meta-analysis of bleeding and thromboembolic rates. Journal of Thrombosis and Haemostasis. 604-604. 2011
- 241: Neurological complications in the recipients of allogeneic hematopoietic cell transplant. Transplantation and Cellular Therapy. 88-89. 2007
- Preliminary report of clinical efficacy of patient (pt) specific vaccination using purified idiotype protein in myeloma.. Blood. 704A-704A. 1999
-
journal articles
- Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature Reviews Cardiology. 2024
- Enquête canadienne sur les perceptions et pratiques liées à la prescription de tests sanguins aux soins intensifs. Canadian Journal of Anaesthesia. 2024
- Anticoagulation for mechanical aortic valves: An international survey of current practice patterns and perceptions. Thrombosis Update. 14:100164-100164. 2024
- Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic. Blood Vessels, Thrombosis & Hemostasis. 1:100004-100004. 2024
- Pharmacokinetics of direct oral anticoagulants after bariatric surgery: A retrospective cohort study. Thrombosis Research. 235:15-17. 2024
- Synthetic data in cancer and cerebrovascular disease research: A novel approach to big data. PLoS ONE. 19:e0295921-e0295921. 2024
- When Direct Oral Anticoagulants Should Not Be Standard Treatment. Journal of the American College of Cardiology. 83:444-465. 2024
-
Comment on: 2023 updated
AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of The American Geriatrics Society. 71:3951-3953. 2023 - Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke. Open Heart. 10:e002506-e002506. 2023
- Previous Ischemic Stroke Significantly Alters Stroke Risk in Newly Diagnosed Cancer Patients. Stroke. 54:3064-3073. 2023
- Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care. Journal of the American Medical Association (JAMA). 330:1872-1872. 2023
- Small-volume tubes to reduce anemia and transfusion (STRATUS): a pilot study. Canadian Journal of Anaesthesia. 70:1797-1806. 2023
- Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review. Journal of Thrombosis and Haemostasis. 21:1553-1566. 2023
-
Effect modification of age and hypertension on cancer and prevalence of
self‐reported stroke – A cross‐sectional study. Cancer Medicine. 12:12518-12523. 2023 - Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysis. European Journal of Cardio-thoracic Surgery. 63:ezad110. 2023
- Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. ACP journal club. 176:515-523. 2023
- Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 21:944-952. 2023
- Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. Journal of Thrombosis and Haemostasis. 21:933-943. 2023
- DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature. Journal of Thrombosis and Haemostasis. 21:433-452. 2023
- Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review. Journal of Thrombosis and Thrombolysis. 55:197-202. 2023
- A scoping review protocol on diagnostic strategies to detect occult malignancies in individuals with ischemic stroke. PLoS ONE. 18:e0289048-e0289048. 2023
- How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review. Thrombosis and Haemostasis. 123:006-015. 2023
- Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS ONE. 18:e0293632-e0293632. 2023
- All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis. Systematic Reviews. 11:269. 2022
- Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial. Pilot and Feasibility Studies. 8:166. 2022
- Cancer and stroke: What do we know and where do we go?. Thrombosis Research. 219:133-140. 2022
- No apparent association between mRNA COVID-19 vaccination and venous thromboembolism. Blood Reviews. 56:100970-100970. 2022
- American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Blood Advances. 6:4975-4982. 2022
- American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood Advances. 6:4915-4923. 2022
- Evaluating Anticoagulant Strategies for Atrial Fibrillation in Patients With Cancer. JACC: CardioOncology. 4:351-353. 2022
- Source of upper gastrointestinal bleeding in cancer patients: A cross-sectional study. Thrombosis Research. 217:9-11. 2022
- A Framework for the Development of Living Practice Guidelines in Health Care. ACP journal club. 175:1154-1160. 2022
- Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. Journal of Thrombosis and Haemostasis. 20:1910-1919. 2022
- Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants. JAMA cardiology. 7:747-747. 2022
- Illustrated State‐of‐the‐Art Capsules of the ISTH 2022 Congress. Research and Practice in Thrombosis and Haemostasis. 6:e12747-e12747. 2022
- Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study. BMJ Open. 12:e057991-e057991. 2022
- Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis. 122:830-841. 2022
- Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients—A Systematic Review and Meta-Analysis. Critical Care Medicine. 50:e370-e381. 2022
- Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study. Leukemia Research. 113:106788-106788. 2022
- American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Blood Advances. 6:664-671. 2022
- Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients. Annals of Surgery. 275:19-28. 2022
- Incidence of stroke in the first year after diagnosis of cancer—A systematic review and meta-analysis. Frontiers in Neurology. 13:966190. 2022
- American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Advances. 5:3951-3959. 2021
- Anticoagulant‐associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants. Journal of Thrombosis and Haemostasis. 19:2383-2393. 2021
- Detection of right ventricular dysfunction in acute pulmonary embolism by computed tomography or echocardiography: A systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. 19:2504-2513. 2021
- Media portrayals of pulmonary embolism. Thrombosis Research. 206:52-54. 2021
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. New England Journal of Medicine. 385:777-789. 2021
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. New England Journal of Medicine. 385:790-802. 2021
- Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients. Thrombosis and Haemostasis. 121:1097-1106. 2021
- Correction. Journal of the American College of Cardiology. 77:2760-2760. 2021
- Are the correct outcomes being measured in studies of oral anticoagulants? A systematic survey. Thrombosis Research. 201:30-49. 2021
- Considerations for use of direct oral anticoagulants in arterial disease. Research and Practice in Thrombosis and Haemostasis. 5:e12502-e12502. 2021
- Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM‐Line): A two‐center open‐label pilot randomized controlled trial. Research and Practice in Thrombosis and Haemostasis. 5:e12517-e12517. 2021
- Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease. Heart. 107:667-673. 2021
- Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E304-E309. 2021
- American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Advances. 5:872-888. 2021
- Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more. Thrombosis Research. 198:1-6. 2021
- Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries. Cardioscience. 117:576-584. 2021
- Ciraparantag: the next anticoagulant airbag?. Blood. 137:10-11. 2021
- Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers. PLoS ONE. 16:e0257798-e0257798. 2021
- Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance. British Journal of Anaesthesia. 126:163-171. 2021
- Ethnoracial variations in venous thrombosis: Implications for management, and a call to action. Journal of Thrombosis and Haemostasis. 19:30-40. 2021
- Incidence of stroke in the first year after diagnosis of cancer—A protocol for systematic review and meta-analysis. PLoS ONE. 16:e0256825-e0256825. 2021
- Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health‐care providers. Journal of Thrombosis and Haemostasis. 19:153-160. 2021
- Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study. British Journal of Anaesthesia. 126:172-180. 2021
- Thinking Outside the Inbox: Use of Slack in Clinical Groups as a Collaborative Team Communication Platform. AEM Education and Training. 5:121-129. 2021
- A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies. Blood Advances. 4:6259-6273. 2020
- Characterizing Frailty in Myeloproliferative Neoplasms: Baseline Results from the Orchid Study. Blood. 136:9-10. 2020
- Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts. Research and Practice in Thrombosis and Haemostasis. 4:1251-1261. 2020
- Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review. Journal of Intensive Care Medicine. 35:1074-1079. 2020
- Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Arteriosclerosis, Thrombosis and Vascular Biology. 40:1958-1960. 2020
- Iron deficiency following bariatric surgery: a retrospective cohort study. Blood Advances. 4:3639-3647. 2020
- 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants. Journal of the American College of Cardiology. 76:594-622. 2020
- Intravenous iron therapy for patients with preoperative iron deficiency or anaemia undergoing cardiac surgery reduces blood transfusions: a systematic review and meta-analysis. Interactive Cardiovascular and Thoracic Surgery. 31:141-151. 2020
- Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?. Research and Practice in Thrombosis and Haemostasis. 4:677-679. 2020
- Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk. Heart. 106:845-851. 2020
- Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen?. Canadian Journal of Cardiology. 36:459-461. 2020
- Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study. Transfusion. 60:256-261. 2020
- Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding. Hematology. American Society of Hematology. Education Program. 2019:204-208. 2019
- What we have learned about direct oral anticoagulant reversal. Hematology. American Society of Hematology. Education Program. 2019:198-203. 2019
- Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence. Future Cardiology. 15:395-404. 2019
- Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk. Journal of Thrombosis and Haemostasis. 17:1966-1972. 2019
- Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry. Seminars in Vascular Medicine. 45:793-801. 2019
- Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding. Thrombosis Research. 180:86-86. 2019
- Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis. Thrombosis Research. 179:81-86. 2019
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. New England Journal of Medicine. 380:1326-1335. 2019
- Refractory urticaria and the importance of diagnosing Schnitzler’s syndrome. BMJ Case Reports. 12:e228546-e228546. 2019
- Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis. Thrombosis Research. 175:102-109. 2019
- Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds. Circulation. 139:757-759. 2019
- The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations. Thrombosis and Haemostasis. 119:014-038. 2019
- Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery. Journal of Thrombosis and Haemostasis. 16:2008-2015. 2018
- Antiplatelet use in patients with essential thrombocythemia: A survey of opinion and Canadian practice. Thrombosis Research. 167:6-8. 2018
- The real-world outcomes of treating Polycythemia Vera: Physician adherence to treatment guidelines. Leukemia Research. 70:62-66. 2018
- Pharmacological reversal of the direct oral anticoagulants—A comprehensive review of the literature. Research and Practice in Thrombosis and Haemostasis. 2:251-265. 2018
- Management of direct oral anticoagulant associated bleeding: Results of a multinational survey. Thrombosis Research. 163:19-21. 2018
- 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants. Journal of the American College of Cardiology. 70:3042-3067. 2017
- Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis. Thrombosis Research. 160:97-104. 2017
- Occult Amebic Liver Abscess as Cause of Extensive Inferior Vena Cava and Hepatic Vein Thrombosis. American Journal of Tropical Medicine and Hygiene. 97:1214-1217. 2017
- Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa. Blood Advances. 1:1827-1838. 2017
- Assessing renal function in patients receiving DOACs: Cockcroft-Gault versus estimated glomerular filtration rate. Thrombosis Research. 157:165-166. 2017
- Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia. ACP journal club. 167:170-170. 2017
- Specific antidotes for bleeding associated with direct oral anticoagulants. The BMJ. 357:j2216-j2216. 2017
- Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis. Blood Advances. 1:772-778. 2017
- Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants. Chest. 151:127-138. 2017
- Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. New England Journal of Medicine. 375:1131-1141. 2016
- Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis. Thrombosis and Haemostasis. 116:879-890. 2016
- The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis. Blood. 128:138-140. 2016
- Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. New England Journal of Medicine. 373:2413-2424. 2015
- Monitoring and reversal of direct oral anticoagulants. Hematology. American Society of Hematology. Education Program. 2015:117-124. 2015
- Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review. Hematology. American Society of Hematology. Education Program. 2015:448-453. 2015
- A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal. Journal of Thrombosis and Thrombolysis. 40:231-239. 2015
- Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents. Journal of Thrombosis and Thrombolysis. 39:395-402. 2015
- What is the effect of rivaroxaban on routine coagulation tests?. Hematology. American Society of Hematology. Education Program. 2014:334-336. 2014
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants. Journal of the American College of Cardiology. 64:1128-1139. 2014
- Reversal of target-specific oral anticoagulants. Drug Discovery Today. 19:1465-1470. 2014
- How I treat target-specific oral anticoagulant–associated bleeding. Blood. 123:1152-1158. 2014
- Reversal of novel oral anticoagulants in patients with major bleeding. Journal of Thrombosis and Thrombolysis. 35:391-398. 2013
- Acute management of bleeding in patients on novel oral anticoagulants. European Heart Journal. 34:489-498. 2013
- Corrigendum. Journal of Thrombosis and Haemostasis. 11:221-221. 2013
- Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia. Seminars in Hematology. 50:S18-S21. 2013
- Anticoagulants in cancer. Journal of Thrombosis and Haemostasis. 10:2230-2241. 2012
- Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists. Circulation. 126:1630-1639. 2012
- Acute Hepatic Necrosis and Ischemic Limb Necrosis. New England Journal of Medicine. 367:879-881. 2012
- Liver-kidney transplantation in primary hyperoxaluria type-1: case report and literature review.. International Journal of Organ Transplantation Medicine. 2:126-132. 2011
- Complete heart block following intentional carbamate ingestion. Canadian Journal of Cardiology. 25:e288-e290. 2009
- Type II Bidirectional Ventricular Tachycardia as a Mechanism of Termination of Sustained Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology. 20:345-346. 2009
- Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies. Bone Marrow Transplantation. 42:51-56. 2008
- Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplantation. 41:743-747. 2008
- Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, and Clinical Significance. Transplantation and Cellular Therapy. 13:1369-1379. 2007